Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118379) titled 'Intracavitary Infusion of Adebrelimab combined with the best standard treatment for the Treatment of Pancreatic Cancer with Pleural and Peritoneal Effusions: A Single-center, Prospective, Clinical Trial' on Feb. 4.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Eastern Theater General Hospital of the Chinese People's Liberation Army
Condition:
Pancreatic cancer
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-11-04
Target Sample Size: single-arm:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=28...